New therapeutics offer some hope in this emerging market.
Michael McAlister, PharmD, BCIDP
Advertisement
McAlister is an infectious diseases pharmacist at Orlando Health Dr. P. Phillips Hospital in Orlando, FL. He serves as the PGY-1 Pharmacy Residency Program director and has clinical interests in antimicrobial stewardship, HIV, Gram-negative resistance, and precepting/teaching.
Articles by Michael McAlister, PharmD, BCIDP
Advertisement
Latest Updated Articles
STAY PrEPARED: Understanding COVID-19 Pre-Exposure ProphylaxisPublished: November 10th 2024 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Developing a COVID-19 Vaccine Alternative
2
Generic Lenacapavir Could Cost as Little as $25 Per Person Annually
3
Real-World Data Reinforce Effectiveness and Safety of Fecal Microbiota Therapy for Preventing Recurrent C difficile
4
Building Trust Through Vaccine Education and Science Communication
5
